Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Obstet Gynecol ; 194(4): 1022-6, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16580291

RESUMO

OBJECTIVE: This study was undertaken to evaluate the efficacy and safety of intravaginal administration of glyceryl trinitrate plus dinoprostone versus dinoprostone, for cervical ripening and induction of labor. STUDY DESIGN: A prospective, double-blind, placebo-controlled, randomized clinical trial was conducted among 196 singleton low-risk nullipara women with term pregnancies and unfavorable cervices who were randomly assigned to receive intravaginal glyceryl trinitrate plus dinoprostone or placebo plus dinoprostone. The main outcome variables were time from application to active phase of labor and to delivery. Secondary outcomes were change in Bishop score, fetal and maternal morbidity, and incidence of cesarean deliveries. RESULTS: The interval from application of the initial dose to the beginning of active phase of labor was 868 +/- 582 and 1136 +/- 692 minutes (P = .004) and from initial dose to delivery was 1339 +/- 826 and 1620 +/- 975 minutes (P = .03) for the glyceryl trinitrate and placebo groups, respectively. There were no significant differences in Bishop score change, cesarean section rate, and in the incidence of hypersystole and hyperstimulation. The incidence of tachysystole was significantly lower in the glyceryl trinitrate group (4% vs 15%, P < or = .02). No maternal and neonatal adverse effects were noted. CONCLUSION: The association of glyceryl trinitrate with dinoprostone is more effective than dinoprostone alone for labor induction in low-risk patients at term with unfavorable cervices.


Assuntos
Maturidade Cervical/efeitos dos fármacos , Dinoprostona/administração & dosagem , Trabalho de Parto Induzido , Nitroglicerina/administração & dosagem , Ocitócicos/administração & dosagem , Administração Intravaginal , Adulto , Método Duplo-Cego , Feminino , Humanos , Gravidez , Estudos Prospectivos
2.
Acta Med Port ; 17(2): 180-2, 2004.
Artigo em Português | MEDLINE | ID: mdl-15921650

RESUMO

In the present article, regarding a clinical case of Thrombasthenia of Glanzmann with severe anaemia by menometrorrhagia, the authors propose the vaginal hysterectomy and the administration of the recombinant factor VIIa on the immediate pre and postoperative as effective therapeutical alternatives.


Assuntos
Fator VIIa/uso terapêutico , Histerectomia Vaginal , Metrorragia/etiologia , Metrorragia/cirurgia , Trombastenia/complicações , Adulto , Anemia/etiologia , Terapia Combinada , Feminino , Humanos , Metrorragia/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...